Denali Therapeutics Inc. SEC filings DNLI
Denali Therapeutics Inc. has 789 filings in SEC EDGAR's recent list, going back to Sep 8, 2017. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2026 | Nov 3, 2026 |
| 4 | Insider transaction | Sep 9, 2026 | Sep 4, 2026 |
| 144 | Notice of proposed sale | Sep 4, 2026 | — |
| 4 | Insider transaction | Sep 4, 2026 | Sep 2, 2026 |
| 4 | Insider transaction | Sep 3, 2026 | Sep 1, 2026 |
| 144 | Notice of proposed sale | Sep 2, 2026 | — |
| 144 | Notice of proposed sale | Sep 1, 2026 | — |
| 4 | Insider transaction | Aug 14, 2026 | Aug 12, 2026 |
| 4 | Insider transaction | Aug 13, 2026 | Aug 11, 2026 |
| 144 | Notice of proposed sale | Aug 11, 2026 | — |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 4, 2026 | — |
| 8-K |
Current report
Acquisition or sale of assets
|
Jul 28, 2026 | Jul 27, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 8, 2026 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jun 18, 2026 | Jun 12, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 3, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2026 | Jun 3, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 22, 2026 | May 21, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 6, 2026 | — |
| 3/A | Form 3/a | Apr 21, 2026 | Apr 10, 2026 |
| DEFA14A | Additional proxy material | Apr 21, 2026 | — |
| ARS | Annual report to shareholders | Apr 21, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Apr 21, 2026 | Dec 31, 2025 |
| 3 | Initial insider ownership | Apr 20, 2026 | Apr 10, 2026 |
| 8-K |
Current report
Agreement ended
|
Apr 3, 2026 | Apr 3, 2026 |
| 8-K |
Current report
New debt, Regulation FD disclosure
|
Mar 31, 2026 | Mar 27, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 26, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 25, 2026 | Mar 25, 2026 |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| S-8 | Employee stock plan registration | Feb 26, 2026 | — |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Feb 26, 2026 |
| 144 | Notice of proposed sale | Feb 5, 2026 | — |
| 144 | Notice of proposed sale | Feb 4, 2026 | — |
| 144 | Notice of proposed sale | Feb 3, 2026 | — |
| 4 | Insider transaction | Jan 8, 2026 | Jan 6, 2026 |
| 4 | Insider transaction | Jan 8, 2026 | Jan 6, 2026 |
| 144 | Notice of proposed sale | Jan 6, 2026 | — |
| 144 | Notice of proposed sale | Jan 6, 2026 | — |
| 144 | Notice of proposed sale | Jan 6, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 6, 2026 | Jan 6, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 3, 2026 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 3, 2026 |
| 4 | Insider transaction | Dec 15, 2025 | Dec 11, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Dec 10, 2025 | Dec 9, 2025 |
| 424B5 | Prospectus supplement | Dec 10, 2025 | — |
| 424B5 | Prospectus supplement | Dec 9, 2025 | — |
| 144 | Notice of proposed sale | Dec 4, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 4, 2025 | Dec 4, 2025 |
| 8-K |
Current report
Material agreement
|
Dec 4, 2025 | Dec 4, 2025 |
| 4 | Insider transaction | Nov 6, 2025 | Nov 4, 2025 |
| 3 | Initial insider ownership | Nov 6, 2025 | Nov 4, 2025 |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 5, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 14, 2025 | Oct 13, 2025 |
| 4 | Insider transaction | Sep 5, 2025 | Sep 3, 2025 |
| 4 | Insider transaction | Aug 14, 2025 | Aug 12, 2025 |
| 4 | Insider transaction | Aug 14, 2025 | Aug 12, 2025 |
| 144 | Notice of proposed sale | Aug 13, 2025 | — |
| 144 | Notice of proposed sale | Aug 12, 2025 | — |
| 144 | Notice of proposed sale | Aug 12, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 12, 2025 | — |
| 10-Q | Quarterly report | Aug 11, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2025 | Aug 11, 2025 |
| 4 | Insider transaction | Aug 7, 2025 | Aug 5, 2025 |
| 4 | Insider transaction | Jul 11, 2025 | Jul 9, 2025 |
| 144 | Notice of proposed sale | Jul 9, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 7, 2025 | Jul 7, 2025 |
| 4 | Insider transaction | Jun 5, 2025 | Jun 3, 2025 |
| 3 | Initial insider ownership | Jun 5, 2025 | Jun 3, 2025 |
| 3 | Initial insider ownership | Jun 5, 2025 | Jun 3, 2025 |
| 4 | Insider transaction | Jun 5, 2025 | Jun 3, 2025 |
| 4 | Insider transaction | Jun 5, 2025 | Jun 3, 2025 |
| 4 | Insider transaction | Jun 5, 2025 | Jun 3, 2025 |
| 4 | Insider transaction | Jun 5, 2025 | Jun 3, 2025 |
| 4 | Insider transaction | Jun 5, 2025 | Jun 3, 2025 |
| 4 | Insider transaction | Jun 5, 2025 | Jun 3, 2025 |
| 4 | Insider transaction | Jun 5, 2025 | Jun 3, 2025 |
| 8-K |
Current report
Material agreement, Shareholder vote results
|
Jun 3, 2025 | Jun 3, 2025 |
| 10-Q | Quarterly report | May 6, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 6, 2025 | May 6, 2025 |
| ARS | Annual report to shareholders | Apr 17, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 17, 2025 | — |
| DEF 14A | Proxy statement | Apr 17, 2025 | Dec 31, 2024 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 17, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 2, 2025 | Apr 2, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 5, 2025 | Mar 5, 2025 |
| S-8 | Employee stock plan registration | Feb 27, 2025 | — |
| 8-K |
Current report
Material agreement, Agreement ended, Results of operations
|
Feb 27, 2025 | Feb 27, 2025 |
| S-3ASR | Automatic shelf registration | Feb 27, 2025 | — |
| 10-K | Annual report | Feb 27, 2025 | Dec 31, 2024 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 4 | Insider transaction | Jan 8, 2025 | Jan 6, 2025 |
| 4 | Insider transaction | Jan 8, 2025 | Jan 6, 2025 |
| 4 | Insider transaction | Jan 8, 2025 | Jan 6, 2025 |
| 4 | Insider transaction | Jan 8, 2025 | Jan 7, 2025 |
| 144 | Notice of proposed sale | Jan 7, 2025 | — |
| 144 | Notice of proposed sale | Jan 7, 2025 | — |
| 144 | Notice of proposed sale | Jan 7, 2025 | — |
| 144 | Notice of proposed sale | Jan 7, 2025 | — |
| 144 | Notice of proposed sale | Jan 7, 2025 | — |
| 144 | Notice of proposed sale | Jan 7, 2025 | — |
| 144 | Notice of proposed sale | Jan 7, 2025 | — |
| 4 | Insider transaction | Jan 7, 2025 | Jan 3, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 3, 2025 |
| 4 | Insider transaction | Jan 7, 2025 | Jan 3, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 7, 2025 | Jan 6, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 2, 2025 |
| 144 | Notice of proposed sale | Jan 2, 2025 | — |
| 4 | Insider transaction | Dec 31, 2024 | Dec 27, 2024 |
| 144 | Notice of proposed sale | Dec 31, 2024 | — |
| 4 | Insider transaction | Nov 27, 2024 | Nov 25, 2024 |
| 4 | Insider transaction | Nov 26, 2024 | Nov 22, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Nov 18, 2024 | Nov 12, 2024 |
| 4 | Insider transaction | Nov 13, 2024 | Nov 11, 2024 |
| 4 | Insider transaction | Nov 12, 2024 | Nov 7, 2024 |
| 4 | Insider transaction | Nov 12, 2024 | Nov 7, 2024 |
| SC 13G | Ownership over 5% (passive) | Nov 12, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| 144 | Notice of proposed sale | Nov 12, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 8, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 8, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 7, 2024 | — |
| 144 | Notice of proposed sale | Nov 7, 2024 | — |
| 10-Q | Quarterly report | Nov 6, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2024 | Nov 6, 2024 |
| 4 | Insider transaction | Nov 5, 2024 | Nov 1, 2024 |
| 4 | Insider transaction | Oct 22, 2024 | Oct 18, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Oct 21, 2024 | — |
| 144 | Notice of proposed sale | Oct 18, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 10, 2024 | Oct 10, 2024 |
| 4 | Insider transaction | Oct 2, 2024 | Sep 30, 2024 |
| 144 | Notice of proposed sale | Sep 30, 2024 | — |
| 4 | Insider transaction | Sep 16, 2024 | Sep 13, 2024 |
| 144 | Notice of proposed sale | Sep 13, 2024 | — |
| 4 | Insider transaction | Sep 4, 2024 | Sep 3, 2024 |
| 4 | Insider transaction | Aug 22, 2024 | Aug 20, 2024 |
| 4 | Insider transaction | Aug 22, 2024 | Aug 20, 2024 |
| 4 | Insider transaction | Aug 22, 2024 | Aug 20, 2024 |
| 4 | Insider transaction | Aug 22, 2024 | Aug 20, 2024 |
| 144 | Notice of proposed sale | Aug 21, 2024 | — |
| 144 | Notice of proposed sale | Aug 21, 2024 | — |
| 144 | Notice of proposed sale | Aug 20, 2024 | — |
| 144 | Notice of proposed sale | Aug 20, 2024 | — |
| 144 | Notice of proposed sale | Aug 20, 2024 | — |
| 144 | Notice of proposed sale | Aug 20, 2024 | — |
| 144 | Notice of proposed sale | Aug 20, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Aug 16, 2024 | — |
| 4 | Insider transaction | Aug 15, 2024 | Aug 13, 2024 |
| 4 | Insider transaction | Aug 15, 2024 | Aug 13, 2024 |
| 144 | Notice of proposed sale | Aug 13, 2024 | — |
| 144 | Notice of proposed sale | Aug 13, 2024 | — |
| 10-Q | Quarterly report | Aug 1, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 1, 2024 | Aug 1, 2024 |
| 4 | Insider transaction | Jul 3, 2024 | Jun 13, 2024 |
| 4 | Insider transaction | Jul 3, 2024 | Jul 1, 2024 |
| 144 | Notice of proposed sale | Jul 1, 2024 | — |
| 144 | Notice of proposed sale | Jul 1, 2024 | — |
| 4 | Insider transaction | Jun 10, 2024 | Jun 6, 2024 |
| 144 | Notice of proposed sale | Jun 6, 2024 | — |
| 4 | Insider transaction | Jun 4, 2024 | May 31, 2024 |
| 4 | Insider transaction | Jun 4, 2024 | May 31, 2024 |
| 4 | Insider transaction | Jun 4, 2024 | May 31, 2024 |
| 4 | Insider transaction | Jun 4, 2024 | May 31, 2024 |
| 4 | Insider transaction | Jun 4, 2024 | May 31, 2024 |
| 4 | Insider transaction | Jun 4, 2024 | May 31, 2024 |
| 4 | Insider transaction | Jun 4, 2024 | May 31, 2024 |
| 4 | Insider transaction | Jun 4, 2024 | May 31, 2024 |
| 4 | Insider transaction | Jun 4, 2024 | May 31, 2024 |
| 8-K |
Current report
Shareholder vote results
|
May 31, 2024 | May 31, 2024 |
| 4 | Insider transaction | May 17, 2024 | May 15, 2024 |
| 10-Q | Quarterly report | May 7, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 7, 2024 | May 7, 2024 |
| ARS | Annual report to shareholders | Apr 18, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 18, 2024 | — |
| DEF 14A | Proxy statement | Apr 18, 2024 | Dec 31, 2023 |
| 4 | Insider transaction | Apr 17, 2024 | Apr 15, 2024 |
| 144 | Notice of proposed sale | Apr 15, 2024 | — |
| 4 | Insider transaction | Apr 2, 2024 | Apr 1, 2024 |
| 144 | Notice of proposed sale | Apr 1, 2024 | — |
| 4 | Insider transaction | Mar 29, 2024 | Mar 29, 2024 |
| S-3ASR | Automatic shelf registration | Mar 22, 2024 | — |
| 4 | Insider transaction | Mar 19, 2024 | Mar 15, 2024 |
| D | Filing | Mar 1, 2024 | — |
| S-8 | Employee stock plan registration | Feb 28, 2024 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- DNLI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1714899
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.